EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clinical Manifestations of Subjective Sleep Disorders in Chinese Patients with Parkinson’s Disease and Their Relationship with Dopaminergic Drugs

Dongdong Wu, Jing He, Kai Li, Huijing Liu, Ying Jin, Wei Du, Xinxin Ma, Yunfei Long, Shuhua Li, Wen Su, Haibo Chen

European Neurology · 2023

DOI: 10.1159/000533905 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Neurology, 2023. Verfasst von Dongdong Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beij…. Hauptthemen laut MEDLINE: Parkinson Disease, Sleep Wake Disorders. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Sleep disorders are common in Parkinson’s disease (PD) and significantly impact quality of life. Herein, we surveyed the incidence and severity of sleep disorders in Chinese PD patients and observed their relationship with dopaminergic drugs.

Methods

We collected the demographic and disease information of 232 PD patients. The incidence and severity of sleep disorders were surveyed with the Parkinson’s disease sleep scale (PDSS) Chinese version. Data on dopaminergic drug intake were collected and converted to levodopa equivalent doses (LED).

Results

The average total score of PDSS in 232 patients was 119.3 ± 19.7. There was a significant difference in PDSS scores between groups classified by the Hoehn-Yahr (H&Y) stage, but not between the groups classified by the type of dopaminergic drugs. Stepwise regression analysis revealed that the LED of dopaminergic drugs taken before bedtime (p < 0.00), LED of dopaminergic drugs taken over a 24-h period (p < 0.00), and scores of the Hamilton Rating Scale for Depression (HAMD) (p = 0.01) were determinants of PDSS.

Conclusion

Sleep disorders in PD patients may be multifactorial. High dosage of dopaminergic drugs taken prior to sleep, daily total high dosage of dopaminergic drugs, and depression exert negative effects on subjective sleep. The timing and dosage of dopaminergic drugs taken before bedtime should be considered in PD management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseSleep Wake DisordersHumansQuality of LifeDopamine AgentsSleepLevodopa

Stichwörter der Autor:innen

Dopaminergic agonistLevodopaParkinson’s diseaseParkinson’s disease sleep scaleSleep disorders

Substanzen

Dopamine AgentsLevodopa

Autor:innen und Institutionen

  • Department of Neurology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.

Zitieren

APA

Wu, D., He, J., Li, K., Liu, H., Jin, Y., Du, W., Ma, X., Long, Y., Li, S., Su, W., & Chen, H. (2023). Clinical Manifestations of Subjective Sleep Disorders in Chinese Patients with Parkinson’s Disease and Their Relationship with Dopaminergic Drugs. European Neurology. https://doi.org/10.1159/000533905

Vancouver

Wu D, He J, Li K, Liu H, Jin Y, Du W, et al. Clinical Manifestations of Subjective Sleep Disorders in Chinese Patients with Parkinson’s Disease and Their Relationship with Dopaminergic Drugs. European Neurology. 2023. doi:10.1159/000533905

BibTeX
@article{Wu2023,
  author = {Wu, Dongdong and He, Jing and Li, Kai and Liu, Huijing and Jin, Ying and Du, Wei and Ma, Xinxin and Long, Yunfei and Li, Shuhua and Su, Wen and Chen, Haibo},
  title = {Clinical Manifestations of Subjective Sleep Disorders in Chinese Patients with Parkinson’s Disease and Their Relationship with Dopaminergic Drugs},
  journal = {European Neurology},
  year = {2023},
  doi = {10.1159/000533905}
}
Kostenlos starten →